Printable PDF Version - Gore Medical
Printable PDF Version - Gore Medical Printable PDF Version - Gore Medical
U P C O M I N G E V E N T S Please Join Us... The Society for Cardiovascular Angiography (SCAI) May 4 – 7, 2011 Baltimore, Maryland Pediatric Inteventional Cardio Society (PICS) July 24 – 27, 2011 Boston, Massachusetts Congenital and Structural Interventions (CSI - iCi) June 22 – 25, 2011 Frankfurt, Germany 2011 GORE MEDICAL MASTERY SERIES Courses Atrial Septal Defect Closure July 14 – 15 Detroit, Michigan August 18 – 19 Chicago, Illinois September 8 – 9 Detroit, Michigan October 20 – 21 Chicago, Illinois Gore’s commitment to excellence continues with the GORE MEDICAL MASTERY SERIES. The Atrial Septal Defect Closure courses provide Interventional Cardiologists with the opportunity to develop their knowledge of implant techniques. Contact your local Gore Sales Associate for further information regarding these various course opportunities. If you have a topic that you would like us to consider in a future issue of Closing Remarks, please contact your local Gore Sales Associate or e-mail ClosingRemarks@wlgore.com W. L. Gore & Associates, Inc. Flagstaff, AZ 86004 +65.67332882 (Asia Pacific) 800.437.8181 (United States) 00800.6334.4673 (Europe) 928.779.2771 (United States) goremedical.com INDICATIONS FOR USE IN THE US: The GORE ® HELEX Septal Occluder is a permanently implanted prosthesis indicated for the percutaneous, transcatheter closure of ostium secundum atrial septal defects (ASDs). INDICATIONS FOR USE UNDER CE MARK: The GORE ® HELEX Septal Occluder is a permanently implanted prosthesis indicated for the percutaneous, transcatheter closure of atrial septal defects (ASDs), such as ostium secundum and patent foramen ovale. Refer to Instructions for Use at goremedical.com for a complete description of all contraindications, warnings, precautions and adverse events. Products listed may not be available in all markets. AMPLATZER ® is a trademark of AGA Medical Corporation. GORE ® , GORE-TEX ® , HELEX, PERFORMANCE BY DESIGN, and designs are trademarks of W. L. Gore & Associates. © 2011 W. L. Gore & Associates, Inc. AQ4478-EN2 APRIL 2011
- Page 1 and 2: Closing Rem a rk s In This I S S U
- Page 3 and 4: was exchanged for a 10 Fr introduce
- Page 5 and 6: friction contributed to a non optim
- Page 7: I N T H E N E W S Gore Launches Imp
U P C O M I N G E V E N T S<br />
Please Join Us...<br />
The Society for Cardiovascular Angiography (SCAI)<br />
May 4 – 7, 2011 Baltimore, Maryland<br />
Pediatric Inteventional Cardio Society (PICS)<br />
July 24 – 27, 2011 Boston, Massachusetts<br />
Congenital and Structural Interventions (CSI - iCi)<br />
June 22 – 25, 2011 Frankfurt, Germany<br />
2011 GORE MEDICAL MASTERY SERIES Courses<br />
Atrial Septal Defect Closure<br />
July 14 – 15<br />
Detroit, Michigan<br />
August 18 – 19 Chicago, Illinois<br />
September 8 – 9 Detroit, Michigan<br />
October 20 – 21 Chicago, Illinois<br />
<strong>Gore</strong>’s commitment to excellence continues with the GORE MEDICAL MASTERY SERIES.<br />
The Atrial Septal Defect Closure courses provide Interventional Cardiologists with the<br />
opportunity to develop their knowledge of implant techniques. Contact your local <strong>Gore</strong><br />
Sales Associate for further information regarding these various course opportunities.<br />
If you have a topic that you would like us to consider in a future issue of Closing Remarks,<br />
please contact your local <strong>Gore</strong> Sales Associate or e-mail ClosingRemarks@wlgore.com<br />
W. L. <strong>Gore</strong> & Associates, Inc.<br />
Flagstaff, AZ 86004<br />
+65.67332882 (Asia Pacific) 800.437.8181 (United States)<br />
00800.6334.4673 (Europe) 928.779.2771 (United States)<br />
goremedical.com<br />
INDICATIONS FOR USE IN THE US: The GORE ® HELEX Septal Occluder is a permanently implanted prosthesis indicated for the percutaneous, transcatheter<br />
closure of ostium secundum atrial septal defects (ASDs). INDICATIONS FOR USE UNDER CE MARK: The GORE ® HELEX Septal Occluder is a permanently<br />
implanted prosthesis indicated for the percutaneous, transcatheter closure of atrial septal defects (ASDs), such as ostium secundum and patent foramen<br />
ovale. Refer to Instructions for Use at goremedical.com for a complete description of all contraindications, warnings, precautions and adverse events.<br />
Products listed may not be available in all markets.<br />
AMPLATZER ® is a trademark of AGA <strong>Medical</strong> Corporation.<br />
GORE ® , GORE-TEX ® , HELEX, PERFORMANCE BY DESIGN, and designs are trademarks of W. L. <strong>Gore</strong> & Associates.<br />
© 2011 W. L. <strong>Gore</strong> & Associates, Inc. AQ4478-EN2 APRIL 2011
Change language